The reverse stock split was implemented by the Company in support of its application to list on the NASDAQ Capital Market ("Nasdaq"). The reverse split is intended to increase the per share stock ...

The Reverse Stock Split will reduce the number of outstanding Class A Ordinary Shares of the Company from 7,302,819 to approximately 730,282 Class A Ordinary Shares.

This Reverse Stock Split was approved by the board of directors of the Company on April 11, 2025 and by the Company's shareholders at the shareholders meeting held on May 8, 2024, where ...

The new CUSIP number for the Common Stock will be 02262M605. The reverse stock split is part of the Company’s plan to maintain compliance with the minimum bid price requirement of $1.00 per ...

NEW YORK, NY / ACCESS Newswire / April 29, 2025 / Protagenic Therapeutics, Inc. (Nasdaq:PTIX) ("Protagenic Therapeutics" or the "Company"), a leader in biopharmaceutical innovation, today ...

The primary objective of the Reverse Stock Split is to increase the per share market price of the Series A Common Stock to regain compliance with the minimum bid price requirement for continued ...

America, Inc. (PRKA), today announced that, it will effect a 1-for-500 reverse stock split (the “Reverse Stock Split”) of the shares of the Company’s common stock, followed immediately by a ...

Presidio Property Trust will implement a 1-for-10 reverse stock split to maintain Nasdaq listing compliance, effective May 19, 2025. Presidio Property Trust, Inc. announced a 1-for-10 reverse ...

The new CUSIP number for the Common Stock will be 02262M605. The reverse stock split is part of the Company's plan to maintain compliance with the minimum bid price requirement of $1.00 per share ...

PINE MOUNTAIN, Georgia, April 30, 2025 (GLOBE NEWSWIRE) -- Parks! America, Inc. (OTCPink: PRKA), today announced that, it will effect a 1-for-500 reverse stock split (the "Reverse Stock Split”) of the ...